MedPath

FLUCLOX-125 PWS 125MG/5ML

FLUCLOX-125 PWS 125MG/5ML

Discontinued
DIN Number

02042134

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

wyeth-ayerst canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02042134
AIG Number0113845003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01CF05 FLUCLOXACILLIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationOral
AHFS Classification08:12.16.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

FLOXACILLIN (FLOXACILLIN SODIUM)Active
Strength: 125 MG / 5 ML
Monograph: FLOXACILLIN (FLOXACILLIN SODIUM)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.